2. 2
Ovarian Cancer
General Introduction
Ovarian tumors are
commonest between 30
and 60.
They are particularly
liable to be or to become
malignant.
In their early stages, they
are asymptomatic and
painless.
They may grow to a
large size.
1.4% lifetime risk of
ovarian cancer
3. 3
Ovarian Cancer
Risk Factors
Family history
Ovarian cancer
Breast cancer
Colon cancer
Genetic factors
Older age
Caucasian
More menstrual circles during lifetime
(Ovulation induction)
4. 4
Ovarian Cancer
Incidence
Nearly 25% of all ovarian neoplasm are
malignant.
Approximately 80 % of them are primary
growths of the ovary.
The remainder being secondary , usually
carcinomata.
5. 5
Ovarian Cancer by dr Saleh Bakar
symptoms
Lack of any specific symptoms,
ovarian tumors are often large by
the time the doctor is consulted.
Menstrual function is seldom upset,
and any irregularity is attributed to the
patient’s ‘time of life’.
7. 7
Ovarian Cancer
symptoms
Pressure symptoms
Gastro-intestinal symptoms (Bloating)
Urge to urinate
pelvic pain (a dull pain in the lower abdomen)
Very large tumors may cause respiratory
embarrassment and edema or varicosities in
the legs, and a characteristic ‘ ovarian
cachexia’ develops.
11. 11
Ovarian Cancer
General Rule
An experienced examiner will
recognize an ovarian tumor mainly
because ovarian tumor is, in the
circumstances, the most likely
diagnosis. All abdominal swellings
should be subjected to ultrasound and
X-ray examination.
DIFFERENTIAL DIAGNOSIS
13. 13
Ovarian Cancer
ASCITES
A fluid thrill
may be elicited
from an ovarian
cyst, and ascites
and tumor may
coexist; but as a
rule the
distinction should
be easily made.
DIFFERENTIAL DIAGNOSIS
14. 14
Ovarian Cancer
Uterine Fibroids
A large midline
intramural fibroid may
be impossible to
distinguish from a solid
ovarian tumor until the
abdomen is opened and
an entirely different
surgical problem
encountered.
DIFFERENTIAL DIAGNOSIS
18. 18
Ovarian Cancer
Histological Classification
Most tumors arise from the ovarian
stroma and germinal epithelium. The
embryonic coelom from which that
epithelium develops also gives rise to the
Mullerian duct from which develop the
structures of the genital tract, and it is
this common origin which explains the
great variety of epithelial patterns which
are met with.
19. 19
Ovarian Cancer
Primary Epithelial
TumorMucinous cystadenoma or cystadencarcinoma
(of. Cervical epithelium).
Serous cystadenoma or cystadenocarcinoma
(of . tubal epithelium).
Endometrioma or Endometrioid carcinoma
(of. Endometrium).
Clear cell carcinoma.
Brenner tumour.
Squamous cell tumor
23. 23
Ovarian Cancer
Mucinous cystadenoma
A unilocular or
multilocular cyst of ovary
lined by tall columnar
epithelium resembling that
of the cervix or large
intestine. It is usually large
and may reach immense
proportions, occupying the
whole peritoneal cavity and
compressing other organs.
It may occur at any age.
27. 27
Ovarian Cancer
SEROUS CYSTADENOMA
A unilocular or multilocular
cyst lined by epithelium
similar to the fallopian tube.
They are the most common
benign epithelial tumors and
form 20% of all ovarian
neoplasm. In 10% of cases they
are bilateral. It is uncommon
to find them large than a fetal
head.
31. 31
Ovarian Cancer
Serous cystadenocarcinoma
This is by far the commonest
primary carcinoma, accounting for
60% of all cases, and in over half
the cases it is bilateral. The cysts
are always of papillary type and the
epithelium burrowing through the
capsule produces papillary
processes on the serous surface.
Extension of the growth to the
pelvis and adjacent organs fixes the
tumor. Ascites is always present.
32. 32
Ovarian Cancer
Endometrioid Carcinoma of the Ovary
It is now recognized that
carcinoma of the ovary
may be of endometrial
type, sometimes arising in
endometrioma. Attacks of
pain, unusual with ovarian
cancer, are common.
Sometimes there is uterine
bleeding in post-
menopausal cases.
33. 33
Ovarian Cancer
Endometrioid Carcinoma of the
Ovary
Usually the lesion is cystic
and chocolate brown in color.
If such a cyst ruptures
spontaneously, malignancy
should be suspected. The
histology varies as in uterine
carcinoma. It may be a well-
differentiated adenocarcinoma,
an adeno-acanthoma, mucinous
adenocarcinoma or clear-celled
carcinoma.
34. 34
Ovarian Cancer
Fibroma
This is composed of
fibrous tissue and
resembles fibromata found
elsewhere. It is most
common in the elderly and
accounts for 4-5% of all
ovarian neoplasm.
The fibroma is believed
by many to be a thecoma
which has undergone
fibrous transformation. It
is sometimes associated
with Meig’s syndrome.
36. 36
Ovarian Cancer
Estrogen-producing Tumors
In childhood there is accelerated skeletal
growth and appearance of sex hair.
5% occur in children precocious puberty.
60% occur in child-bearing years irregular
menstruation.
30% occur in post-menopausal women post-
menopausal bleeding.
37. 37
Ovarian Cancer
Andorogen-producing Tumours
Three distinct types of masculinising
ovarian tumor are recognised: a) Sertoli-
Leydig cell tumor (Androblastoma), b)
Hilar cell tumor, c) Lipoid cell tumor. All
three cause amenorrhoea.
38. 38
Ovarian Cancer
Dysgerminoma
This is the only solid
ovarian tumor of
characteristic appearance.
Usually ovoid with a
smooth capsule, it is of
rubbery consistency and
greyish colour. It is
commonest in younger
age groups, under 30
years as a rule, and is
often bilateral. Sometimes
it is found in cases of
intersex.
51. 51
Ovarian Cancer
Spread -Lymphatics
Ovarian drainage is to the para-aortic
glands, but sometimes to the pelvic and
even inguinal groups. Cells seeded on to
the peritoneum are drained via the
lymphatic channels on the underside of
the diaphragm into the subpleural
glands and thence to the pleura.
53. 53
Ovarian Cancer
Staging of ovarian cancer
STAGE I Growth limited to ovaries
Ia Limited to one ovary. No ascites.
Ib Limited to both ovaries. No ascites.
Ic Ascites or positive peritoneal washings also present or
tumour on surface of one or both ovaries or capsule ruptured.
54. 54
Ovarian Cancer
Staging of ovarian cancer
STAGE II Pelvic extension
IIa Spread to uterus/tubes
IIb Spread to other pelvic tissues
IIc IIb with ascites or positive peritoneal washings or tumour
on surface of one or both ovaries or capsule ruptured.
55. 55
2006-11-1 七年制 Ovarian Cancer
Staging of ovarian cancer
Stage III Extrapelvic intraperitoneal spread and/or retroperitoneal
or inguinal positive nodes, or superficial lover metastases.
IIIa Apparent limitation to true pelvis
IIIb Histologically proven abdominal peritoneal superficial
implants<2cm diameter.
IIIc Abdominal implants>2cm diameter or positive
retroperitoneal or inguinal nodes.
56. 56
Ovarian Cancer
Staging of ovarian cancer
Stage IV
Distant metastases
or pleural effusion
with positive
cyotlogy or
parenchymal liver
metastases.
64. 64
Ovarian Cancer
TORSION of the PEDICLE
The commonest
complication
Occur with any
tumor
Except those
with adhesions
65. 65
Ovarian Cancer
Clinical Features-Subacute
The patient complains of recurrent
abdominal pain which passes off as the
pedicle untwists. There is a rise in pulse
and temperature during the bleeding;
And over a period anemia develops.
TORSION of the PEDICLE
66. 66
Ovarian Cancer
Clinical Features-acute
The signs and symptoms are those of an
acute abdominal condition. The problem
becomes one of differential diagnosis to
exclude those conditions in which laparotomy
is not needed and laparoscopy may be useful.
Pain tends to be intense and
continuous.
ORSION of the PEDICLE
67. 67
Ovarian Cancer
Ruptured Cyst
This may occur alone or in conjunction with
torsion. Rupture is not particularly upsetting to the
patient unless the contents are irritant.
TORSION of the PEDICLE
68. 68
Ovarian Cancer
Suggestive of Malignancy
Age. If the patient is over 50 the chance of
malignancy is over 50% as opposed to less
than 15% in premenopausal women.
Tumors in childhood are usually malignant.
Rapid growth.
Ascites.
69. 69
Ovarian Cancer
Suggestive of Malignancy
Solid tumours, especially when bilateral.
Multilocular cysts with solid areas. (At least
10% of cysts are malignant).
Pain. Pressure pain can occur with any tumor;
But referred pain suggests malignant
involvement of nerve roots.
Tumor markers, such as CA125, may be
measured in the blood, but a normal level does
not exclude malignancy.
71. 71
Ovarian Cancer
Surgical Procedures
To classify the growth according to its
extent of spread (staging) as accurately as
possible.
To remove as much cancerous tissue as
possible (‘surgical debulking’;’cyto-
reductive treatment’).
72. 72
Ovarian Cancer
Surgical Procedures
Benign ovarian over 10 cm in diameter
must be removed, but clinical and
ultrasonically diagnosed cysts under 10 cm
(the size of a lemon) in women under 35
years may be reviewed in a few months if
there is no suspicion of malignancy. A
follicular or luteral cyst may resolve
spontaneously.
76. 76
Ovarian Cancer
Follow-up
Follow-up with intensive
chemotherapy, using various
combinations of antineoplastic
drugs. Taxanes, probably combined
with platinum compounds, are an
appropriate first choice.
77. 77
Ovarian Cancer
Second Look
A ‘second look’ laparotomy or laparoscopy
operation (SLO), to determine the actual
effectiveness of the chemotherapy and to
decide whether it should be stopped does not
affect prognosis, so should only be performed
with informed consent in clinical trials.
78. 78
Ovarian Cancer
Surgical Procedures -Incision
A vertical incision which can
be extended is essential to allow a
full inspection. Reduction of a
cyst by tapping and extraction
through a suprapubic incision is
not acceptable practice.
79. 79
Ovarian Cancer
Surgical Procedures - Cytology
Before handling the tumour, take
specimens of ascitic fluid or peritoneal
saline washings for cytological
examination, and a cytology smear
from the underside of the diaphragm.
82. Prophylaxis
I popularization of cancer prevention knowledge
II. health education: physical and gyn. Examination, CA125
and HE4,US examination
III. Early treatment
85. 85
Ovarian Cancer
Hereditary Breast and Ovarian
Cancer: BRCA1
• Autosomal Dominant TransmissionAutosomal Dominant Transmission
• Precise Risk for Male Breast Cancer UnclearPrecise Risk for Male Breast Cancer Unclear
• Increased Risk for Prostate Cancer?Increased Risk for Prostate Cancer?
Breast cancerBreast cancer 50%50%−−85%85%
Second primary breast cancerSecond primary breast cancer 40%40%−−60%60%
Ovarian cancerOvarian cancer 20%20%−−60%60%
86. 86
Ovarian Cancer
Hereditary Breast and Ovarian
Cancer: BRCA2
• Autosomal Dominant TransmissionAutosomal Dominant Transmission
• Increased risk of prostate, laryngeal,Increased risk of prostate, laryngeal,
melanoma and pancreas cancersmelanoma and pancreas cancers
breast cancerbreast cancer
(50%(50%−−85%)85%)
ovarian cancerovarian cancer
(10%(10%−−20%)20%)
male breast cancermale breast cancer
(6%)(6%)